Search
Search Results
##search.searchResults.foundPlural##
-
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277948PDF: 1914HTML: 3916 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4235PDF: 1651HTML: 9332Untitled: 345Untitled: 232Untitled: 218Untitled: 230Untitled: 233Untitled: 393 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7577PDF: 4171HTML: 25001 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
4032PDF: 1393HTML: 984Figure 2: 519Figure 1: 3205 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1466PDF: 1147HTML: 479 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2874PDF: 1117HTML: 2405 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
3106PDF: 1545HTML: 335 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1721PDF: 989HTML: 409 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4440PDF: 2122HTML: 1977 -
SICKLE CELL ANAEMIA AND MALARIA
12120PDF: 7463HTML: 24163Figures Malaria and SCK: 287 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3059PDF: 1060HTML: 7524 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1755PDF: 1206HTML: 278 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4840PDF: 2076HTML: 18239 -
IMMUNOLOGY OF TUBERCULOSIS
5977PDF: 2373HTML: 7380Untitled: 251 -
-
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
8045PDF: 794HTML: 276 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2677PDF: 1426HTML: 1872CoverLetter: 235 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3262PDF: 1095HTML: 3251 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1875PDF: 806HTML: 254 -
EPIDEMIOLOGY OF IMPORTED MALARIA IN THE MEDITERRANEAN REGION
3326PDF: 1163HTML: 16494 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6429PDF: 3509HTML: 9075Figure Malaria Ricci: 288 -
LATERAL SINUS THROMBOSIS IN OTOLOGY: A REVIEW
1740PDF: 1021HTML: 4211Letter: 215 -
-
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2878PDF: 1024HTML: 610 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2645HTML: 363PDF: 986 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3568PDF: 1660HTML: 4096 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1420PDF: 543HTML: 8369 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1297PDF: 947HTML: 313







